Pfizer, BioNTech's mRNA flu vaccine starts phase 3 testing

The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that ... phase 1 testing. Influenza causes ... Read More

Polio Vaccine Effective

A version of this article appears in the April 4, 1953 issue of Science News. Love our Health & Medicine stories? Our coverage would not be possible without the generous support of subscribers to ... Read More

Vaccines News

Optimizing Boosters: How COVID mRNA ... influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA) protein head. The ... Mar. 4, 2024 — A vaccine against ... Read More

Influenza News

29, 2024 — U.S. flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza ... Shows Promise Against Multiple Forms of Flu Virus Dec. 21, 2023 ... Read More

Scientists are testing a modified measles vaccine against coronavirus

The COVID-19 vaccine is based on an existing measles vaccine that has been modified ... virus from taking root inside a host. At present, there is no publicly available vaccine to protect against ... Read More

Science News

Brightest of All Time' gamma-ray burst caused by exploding ... The White House Office of Science and Technology Policy announced it will work to create time standards for the moon and other ... Read More

New Vaccine Could Protect Against Any Strain of a Virus With One Shot

Scientists seem to be close to creating a so-called "universal vaccine" that can protect against any strain of virus and is safe even for the immunocompromised and babies. In a press release from the ... Read More

CureVac, GSK Partner Release Data On Influenza Vaccine Study

Also Read: Moderna’s Vaccine Day: Influenza ... that the multivalent vaccine candidate using CureVac’s proprietary second-generation mRNA backbone boosted antibody titers against all encoded ... Read More

CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK

"The Phase 2 interim data show that CureVac's highly effective and flexible mRNA technology platform puts us on the right track to advance our joint seasonal influenza vaccine program," said Dr ... Read More

Advertise in Science News

Science News is the award-winning, trusted source for clear, credible and concise news in all areas of science. The biweekly magazine — available in print and digital editions — has a print ... Read More

Science news

With every new particle accelerator built for research, scientists have an opportunity to push the limits of discovery. But this is only true if new particle accelerators deliver the desired ... Read More

Science news

Remember #BabyShark? And no, this was not the very catchy song for kids that took the internet by storm. Earlier this year, social media was abuzz with stunning footage of a newborn great white ... Read More